Formation and composition of crust in the nephrostomy tube of patients undergoing percutaneous nephrostomy.
Journal
Medicine
ISSN: 1536-5964
Titre abrégé: Medicine (Baltimore)
Pays: United States
ID NLM: 2985248R
Informations de publication
Date de publication:
16 Dec 2022
16 Dec 2022
Historique:
entrez:
23
12
2022
pubmed:
24
12
2022
medline:
27
12
2022
Statut:
ppublish
Résumé
To investigate the formation and composition of crust in the nephrostomy tube (NT) of patients undergoing percutaneous nephrostomy (PCN). Consecutive patients undergoing PCN for the treatment of obstructive nephropathy who then underwent NT exchange between January 2020 and May 2022 were included in the study. The composition of crust in NTs was analyzed using infrared spectrum automatic analysis system. A total of 46 NTs were collected from 46 consecutive patients (19 men, 27 women; mean age, 68.5 ± 13.4 years) who underwent PCN. The median indwelling time of NTs was 96 days (Q1, 90 days; Q3, 140 days). Among the 46 NTs, 20 (43.5%) were positive for the presence of crust. The mean indwelling time was significantly longer in NTs positive for crust than in those negative for crust (169.7 ± 55.7 days vs 86.5 ± 15.0 days; P < .01). In the NTs positive for crust, the crust was composed of mixed components (apatite carbonate and magnesium ammonium phosphate hexahydrate, n = 7; apatite carbonate and calcium oxalate monohydrate, n = 4) in 11 NTs and a single component (apatite carbonate, n = 5; anhydrous uric acid, n = 2; calcium oxalate monohydrate, n = 2) in 9 NTs. When the NT indwelling time was longer than 3 months, the incidence of crust formation in the NT was significantly increased. Crust was most commonly composed of mixed components. In light of these findings, we suggest that NTs should be exchanged every 3 to 4 months to prevent the formation of crust and thus prevent obstruction of the NT.
Identifiants
pubmed: 36550820
doi: 10.1097/MD.0000000000031607
pii: 00005792-202212160-00028
pmc: PMC9771250
doi:
Substances chimiques
Calcium Oxalate
2612HC57YE
Apatites
0
Carbonates
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e31607Informations de copyright
Copyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc.
Déclaration de conflit d'intérêts
The authors have no funding and conflicts of interest to disclose.
Références
Pabon-Ramos WM, Dariushnia SR, Walker TG, et al. Quality improvement guidelines for percutaneous nephrostomy. J Vasc Interv Radiol. 2016;27:410–4.
Xu ZH, Yang YH, Zhou S, et al. Percutaneous nephrostomy versus retrograde ureteral stent for acute upper urinary tract obstruction with urosepsis. J Infect Chemother. 2021;27:323–8.
Alma E, Ercil H, Vuruskan E, et al. Long-term follow-up results and complications in cancer patients with persistent nephrostomy due to malignant ureteral obstruction. Support Care Cancer. 2020;28:5581–8.
Ključevšek T, Pirnovar V, KljučKljuevščevšek D. Percutaneous nephrostomy in the neonatal period: indications, complications, and outcome-a single centre experience. Cardiovasc Intervent Radiol. 2020;43:1323–8.
Rodrigo Zanon J, Cardoso MS, Mimica MJ, et al. Retrospective analysis of the role of antibiotic prophylaxis in the placement and replacement of percutaneous nephrostomy catheters in patients with malignant ureteral obstruction. J Palliat Med. 2020;23:686–91.
Fernández-Cacho LM, Ayesa-Arriola R. Quality of life, pain and anxiety in patients with nephrostomy tubes. Rev Lat Am Enfermagem. 2019;27:e3191.
Fontenelle LF, Sarti TD. Kidney stones: treatment and prevention. Am Fam Physician. 2019;99:490–6.
Stevens S. Obstructive kidney disease. Nurs Clin North Am. 2018;53:569–78.
Yamashita S, Kohjimoto Y, Higuchi M, et al. Postoperative progress after stone removal following treatment for obstructive acute pyelonephritis associated with urinary tract calculi: a retrospective study. Urol J. 2020;17:118–23.
Zul Khairul Azwadi I, Norhayati MN, Abdullah MS. Percutaneous nephrostomy versus retrograde ureteral stenting for acute upper obstructive uropathy: a systematic review and meta-analysis. Sci Rep. 2021;23:6613.
Khan SR. Reactive oxygen species, inflammation and calcium oxalate nephrolithiasis. Transl Androl Urol. 2014;3:256–76.
Kanlaya R, Sintiprungrat K, Chaiyarit S, et al. Macropinocytosis is the major mechanism for endocytosis of calcium oxalate crystals into renal tubular cells. Cell Biochem Biophys. 2013;67:1171–9.
Wang W, Ma FN, Liu H, et al. Discordance of stone composition in bilateral upper urinary tracts. J Mod Urol. 2019;24:825–32.
Wang C, Cai Y, Yang RQ, et al. Analysis and characterization of urinary stones in Jingmen area of Hubei province. Int J Urol Nephrol. 2020;40:448–52.
Skolarikos A. Medical treatment of urinary stones. Curr Opin Urol. 2018;28:403–7.